Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, August 15, 2022
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
[ Mon, Aug 15th 2022
] - WOPRAI
Fri, August 12, 2022
[ Fri, Aug 12th 2022
] - WOPRAI
[ Fri, Aug 12th 2022
] - WOPRAI
Mayank Mamtani Maintained (ALT) at Strong Buy with Increased Target to $26 on, Aug 12th, 2022
Mayank Mamtani of B. Riley Securities, Maintained "Altimmune, Inc." (ALT) at Strong Buy with Increased Target from $21 to $26 on, Aug 12th, 2022.
Mayank has made no other calls on ALT in the last 4 months.
There is 1 other peer that has a rating on ALT. Out of the 1 peers that are also analyzing ALT, 0 agree with Mayank's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mayank
- Yasmeen Rahimi of "Piper Sandler" Maintained at Buy with Decreased Target to $25 on, Wednesday, May 18th, 2022
